Larimar Therapeutics (LRMR) Non-Current Debt (2014 - 2020)
Larimar Therapeutics' Non-Current Debt came in at $6.75 million for Q1 2020, down 50.1% from $13.53 million a year earlier and down 20.3% from the prior quarter.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Non-Current Debt (2014 - 2020) Analysis & Trends
At the end of FY2019, Larimar Therapeutics' Non-Current Debt was $8.46 million, down 44.3% from FY2018.
- Non-Current Debt carries a five-year compound annual growth rate of 6.5% (FY2014 to FY2019).
- Going back by year, Non-Current Debt was $15.19 million in FY2018 (-24.1%), $20 million in FY2017 and $3.45 million in FY2015 (-44.1%).
- The Q1 2020 figure represents the lowest quarterly Non-Current Debt since Q3 2016.
- Year-over-year, Non-Current Debt has declined for six consecutive quarters, with an average decline of 37.8% over the last six quarters.
- Across the past five years, year-over-year decline in Non-Current Debt ran from 24.1% in Q4 2018 to 71.2% in Q3 2016.
- Business Quant data shows LRMR's Non-Current Debt at $8.46 million (Q4 2019), $10.17 million (Q3 2019) and $11.85 million (Q2 2019) in the three quarters before Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.92 Bn | 1,105.50 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 617.57 Bn | 536.10 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 501.37 Bn | 474.48 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 367.96 Bn | 322.33 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 297.98 Bn | 261.97 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.14 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 236.30 Bn | 191.70 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 190.27 Bn | 164.46 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 169.65 Bn | 116.29 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Larimar Therapeutics | 253.47 Mn | -353.60 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 6.75 Mn |
| Dec 31, 2019 | 8.46 Mn |
| Sep 30, 2019 | 10.17 Mn |
| Jun 30, 2019 | 11.85 Mn |
| Mar 31, 2019 | 13.53 Mn |
| Dec 31, 2018 | 15.19 Mn |
| Sep 30, 2018 | 37.34 Mn |
| Jun 30, 2018 | 38.80 Mn |
| Mar 31, 2018 | 20.20 Mn |
| Dec 31, 2017 | 20.00 Mn |
| Sep 30, 2016 | 1.20 Mn |
| Jun 30, 2016 | 1.97 Mn |
| Mar 31, 2016 | 2.72 Mn |
| Dec 31, 2015 | 3.45 Mn |
| Sep 30, 2015 | 4.16 Mn |
| Jun 30, 2015 | 12.35 Mn |
| Mar 31, 2015 | 13.02 Mn |
| Dec 31, 2014 | 6.18 Mn |
| Sep 30, 2014 | 6.82 Mn |
| Jun 30, 2014 | 7.45 Mn |
API Access
Larimar Therapeutics Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();